Modulating the endocannabinoid system for its vast therapeutic potential is among the most promising fields of current research strategies. Alongside the development of phytocannabinoids for medicinal purposes, another strategy of pharmaceutical companies is to increase the level of endocannabinoids like anandamide (AEA) within our body. This has previously been approached through inhibiting the degradation enzymes […]
FABP5 inhibitors as a novel strategy of modulating the endocannabinoid system is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Be First to Comment